INNOVAFORM Trademark

Trademark Overview


On Tuesday, August 20, 2024, a trademark application was filed for INNOVAFORM with the United States Patent and Trademark Office. The USPTO has given the INNOVAFORM trademark a serial number of 79409988. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 27, 2025. This trademark is owned by Capsugel Belgium NV. The INNOVAFORM trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacturing services of pharmaceuticals, in particular, custom manufacturing of pharmaceuticals using a proprietary technology platform for capsule and any other oral solid dosage forms, and custom manufacture of pharmaceutical encapsulation technologies

Scientific and technological consulting services in the field of pharmaceutical development, specifically for the formulation, customization and encapsulation of capsules and other oral solid dosage forms; scientific and technological consulting services for creating being new product design of pharmaceutical capsule and any other oral solid dosage form delivery solutions; scientific and technological consulting services in relation to new product design capsule and any other oral solid dosage form expertise; product development services using a proprietary technology platform for developing capsule and any other oral solid dosage forms, and product development of encapsulation technologies
innovaform

General Information


Serial Number79409988
Word MarkINNOVAFORM
Filing DateTuesday, August 20, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2025

Trademark Statements


Goods and ServicesCustom manufacturing services of pharmaceuticals, in particular, custom manufacturing of pharmaceuticals using a proprietary technology platform for capsule and any other oral solid dosage forms, and custom manufacture of pharmaceutical encapsulation technologies
Pseudo MarkIN NOVA FORM
Goods and ServicesScientific and technological consulting services in the field of pharmaceutical development, specifically for the formulation, customization and encapsulation of capsules and other oral solid dosage forms; scientific and technological consulting services for creating being new product design of pharmaceutical capsule and any other oral solid dosage form delivery solutions; scientific and technological consulting services in relation to new product design capsule and any other oral solid dosage form expertise; product development services using a proprietary technology platform for developing capsule and any other oral solid dosage forms, and product development of encapsulation technologies

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCapsugel Belgium NV
Party Type20 - Owner at Publication
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Party NameCapsugel Belgium NV
Party Type10 - Original Applicant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Trademark Events


Event DateEvent Description
Thursday, November 21, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 25, 2025ASSIGNED TO EXAMINER
Friday, April 11, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 11, 2025REFUSAL PROCESSED BY MPU
Friday, November 22, 2024APPLICATION FILING RECEIPT MAILED
Thursday, March 6, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 6, 2025NON-FINAL ACTION WRITTEN
Thursday, April 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 25, 2025CORRECTION TRANSACTION RECEIVED FROM IB
Monday, April 28, 2025ATTORNEY REVIEW COMPLETED
Monday, April 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 21, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 27, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 27, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, May 4, 2025REFUSAL PROCESSED BY IB